[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341022-105":59,"doc-detail-341022-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","organoids-in-ovarian-cancer-a-platform-for-disease-modeling-precision-medicine-and-drug-assessment","Organoids in ovarian cancer - a platform for disease modeling, precision medicine, and drug assessment","","Ovarian cancer (OC) is a leading cause of gynecological cancer mortality, demanding stronger research tools. Organoids—3D-grown cellular clusters—offer a disruptive alternative by reproducing key morphological, histological, and genetic features of ovarian tumors. This review covers organoids from murine, healthy human, and patient-derived sources, from foundational principles to advanced uses. Organoids enable patient-specific prediction of treatment responses, support personalized therapy development, and provide versatile preclinical platforms for drug testing and combination evaluation. They also mirror OC progression dynamics, uncovering mechanisms of drug resistance and informing effective treatment strategies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/organoids-in-ovarian-cancer-a-platform-for-disease-modeling-precision-medicine-and-drug-assessment/341022/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/organoids-in-ovarian-cancer-a-platform-for-disease-modeling-precision-medicine-and-drug-assessment/341022.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are organoids considered valuable for ovarian cancer research?","Question",{"text":113,"@type":114},"Organoids grown in 3D can faithfully recapitulate key morphological, histological, and genetic features of ovarian cancer, overcoming limitations of conventional models.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do organoids support precision medicine and personalized therapy?",{"text":118,"@type":114},"Organoids function as patient-specific preclinical models to help predict how patients will respond to treatments and to guide the development of personalized therapies.",{"name":120,"@type":111,"acceptedAnswer":121},"What role do organoids play in evaluating new drugs?",{"text":122,"@type":114},"Organoids act as versatile testing platforms that enable thorough evaluation of innovative drug combinations and novel agents, while reflecting the dynamic nature of ovarian cancer progression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341022,1790507372,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Journal of Cancer Research and Clinical Oncology (2024) 150:146  \n[https://doi.org/10.1007/s00432-024-05654-0](https://doi.org/10.1007/s00432-024-05654-0)  \nOrganoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment  \nHaiyao Hu1,2 · Chong’en Sun1,2 · Jingyao Chen3 · Zhengyu Li1,2  \nReceived: 28 November 2023 / Accepted: 17 February 2024 / Published online: 20 March 2024 © The Author(s) 2024  \nAbstract  \nOvarian cancer (OC) is a major cause of gynecological cancer mortality, necessitating enhanced research. Organoids, cellular clusters grown in 3D model, have emerged as a disruptive paradigm, transcending the limitations inherent to conventional models by faithfully recapitulating key morphological, histological, and genetic attributes. This review undertakes a comprehensive exploration of the potential in organoids derived from murine, healthy population, and patient origins, encompassing a spectrum that spans foundational principles to pioneering applications. Organoids serve as preclinical models, allowing us to predict how patients will respond to treatments and guiding the development of personalized therapies. In the context of evaluating new drugs, organoids act as versatile platforms, enabling thorough testing of innovative combinations and novel agents. Remarkably, organoids mimic the dynamic nature of OC progression, from its initial formation to the spread to other parts of the body, shedding light on intricate details that hold significant importance. By functioning at an individualized level, organoids uncover the complex mechanisms behind drug resistance, revealing strategic opportunities for effective treatments.  \nKeywords Ovarian cancer · Organoid · Cancer modeling · Precision medicine  \nAbbreviations  \nOC Ovarian cancer  \nPARPi Poly-ADP-ribose polymerase inhibitor  \nICI Immune checkpoint inhibitor  \nHRD Homologous recombination deficiency ECM Extracellular matrix  \nCRISPR Clustered regularly interspaced short palindro  \nmic repeats PDO Patient-derived organoid FTE Fallopian tube epithelium  \nOSE Ovarian surface epithelium  \nHGSOC High-grade serous ovarian cancer  \nHaiyao Hu and Chong’en Sun contributed equally.  \n* Zhengyu Li [zhengyuli01@126.com](zhengyuli01@126.com)  \n1 Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China  \n2 Key Laboratory of Obstetrics and Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China  \n3 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China  \nFDA Food and Drug Administration  \nNACT Neoadjuvant chemotherapy treatment RECIST Response Evaluation Criteria in Solid Tumors  \nPFS Progression-free survival  \niPSC Induced pluripotent stem cell KD Knockdown  \nFTM Fallopian tube organoid culture medium OCM Ovarian cancer minimal medium  \nTIMs Tumor-infiltrating mast cells  \nIntroduction  \nOvarian cancer (OC) is the most lethal malignant gynecological tumor and ranks eighth in both cancer incidence and mortality in women worldwide (Sung et al. 2021) . Most patients with OC are diagnosed at advanced stages. More research effort on the molecular mechanism of ovarian tumorigenesis and tumor evolution is urgently needed. The standardized treatment management for OC consists of cytoreductive surgery, chemotherapy, and targeted therapy. Unfortunately, resistance to platinum-based chemotherapy, antiangiogenic targeted therapy, and poly-ADP-ribose polymerase inhibitors (PARPi)-targeted therapy is common, leading to 10-year survival of 15% in patients with  \nadvanced disease (Narod 2016 ; Colombo et al. 2019) . The response of immune checkpoint inhibitor (ICI) monotherapy in patients with OC is unsatisfactory, and the combination of ICI and chemotherapy was also disappointing (Hamanishiet al. 2015 ; Matulonis et al. 2019 ; Kandalaft et al. 2022) ","cbCaiuyhxYNNqO1X","https://ap.wps.com/l/cbCaiuyhxYNNqO1X","pdf",904390,"English","# Abstract\n# Keywords\n## Abbreviations\n# Introduction","[{\"question\":\"Why are organoids considered valuable for ovarian cancer research?\",\"answer\":\"Organoids grown in 3D can faithfully recapitulate key morphological, histological, and genetic features of ovarian cancer, overcoming limitations of conventional models.\"},{\"question\":\"How do organoids support precision medicine and personalized therapy?\",\"answer\":\"Organoids function as patient-specific preclinical models to help predict how patients will respond to treatments and to guide the development of personalized therapies.\"},{\"question\":\"What role do organoids play in evaluating new drugs?\",\"answer\":\"Organoids act as versatile testing platforms that enable thorough evaluation of innovative drug combinations and novel agents, while reflecting the dynamic nature of ovarian cancer progression.\"}]","Organoids in ovarian cancer - a platform for disease modeling, precision medicine, and drug assessment | PDF",1790039995,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3e3ab6d0000e9221e0d88efc04f32e6.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/648c18b532ff2da95ab0b1dd3530dc82.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42275b9908f5053c49e9c34c7500ed4f.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9231442ca9ccdda62194ac7f5ec3a5d8.webp",980,1301]